-
-
-
-
-
-
-
MEDICURE TO REPORT FINANCIAL RESULTS FOR YEAR ENDED DECEMBER 31, 2021 ON APRIL 28TH AT 7:30 AM CST
-
-
-
-
-
-
-
Mereo BioPharma to Present at the 20th Annual Needham Virtual Healthcare Conference
-
-
-
-
-
-
-
Ultragenyx Pharma (RARE), Mereo BioPharma (MREO) Report Collaboration and License Agreement for Setrusumab in Osteogenesis Imperfecta
-
-
-
-
-
-
-
Mereo BioPharma to Present at the Stifel 2020 Virtual Healthcare Conference
-
-
-
-
-
-
-
Mereo BioPharma Announces Initiation of Placebo-Controlled Phase 1b/2 Clinical Trial with Alvelestat in COVID-19 Respiratory Disease
-
-
-
-
-
-
-
Medicure Q1 2020 results and conference call dates
-
-
-
-
-
-
-
Mereo BioPharma Enters into a $5 Million Convertible Equity Financing with Novartis and Announces a Securities Purchase Agreement with Aspire Capital Fund, LLC for up to $28 Million
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

